JOINT FILING AGREEMENT
EXHIBIT
1
This Joint Filing
Agreement dated February 14, 2019 is by and between Camber Capital
Management LP, a Delaware limited partnership, and Xxxxxxx XxXxxx,
an individual (the foregoing are collectively referred to herein as
the "Filers"). Each of the Filers may be required to file with the
United States Securities and Exchange Commission a statement on
Schedule 13G with respect to common stock, $0.001 par value
of Endologix, Inc. beneficially owned by them from time to time.
Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated
under the Securities Exchange Act of 1934, as amended, the Filers
hereby agree to file a single statement on Schedule 13D and/or 13G
(and any amendments thereto) on behalf of each of such parties, and
hereby further agree to file this Joint Filing Agreement as an
exhibit to such statement, as required by such rule. This Joint
Filing Agreement may be terminated by any of the Filers upon one
week's prior written notice or such lesser period of notice as the
Filers may mutually agree.
Executed and
delivered as of the date first above written.
By: /s/ Xxxx
Xxxxxx
Xxxx
Xxxxxx
Chief Financial
Officer
XXXXXXX XXXXXX
By: /s/ Xxxxxxx
XxXxxx
